247 related articles for article (PubMed ID: 17122451)
1. Chronic idiopathic thrombocytopenic purpura: present strategy, guidelines and new insights.
Stevens W; Koene H; Zwaginga JJ; Vreugdenhil G
Neth J Med; 2006 Nov; 64(10):356-63. PubMed ID: 17122451
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic corpus luteum hemorrhage in adolescent females with ITP.
Yelak A; From A; Gilad O; Brik Simon D; Rubin S; Cohen M; Amarilyo G; Levin C; Bakry D; Izraeli S; Tamary H; Yacobovich J; Steinberg-Shemer O
Eur J Pediatr; 2024 Jul; 183(7):2893-2897. PubMed ID: 38602530
[TBL] [Abstract][Full Text] [Related]
3. Conspicuous Peripheral Retinal Hemorrhages with a Relatively Preserved Posterior Pole in Immune Thrombocytopenic Purpura.
Çavdarlı C; Güvenç H; Çomçalı S; Coşkun Ç; Alp MN
Curr Med Imaging; 2024; 20():1-4. PubMed ID: 38389374
[TBL] [Abstract][Full Text] [Related]
4. How I diagnose and treat thrombocytopenia in geriatric patients.
Foy P; Friedman KD; Michaelis LC
Blood; 2024 Jan; 143(3):214-223. PubMed ID: 37956435
[TBL] [Abstract][Full Text] [Related]
5. Broadening the horizon of immune thrombocytopenia through Omics approaches.
Kapur R
Br J Haematol; 2024 Jun; 204(6):2159-2161. PubMed ID: 38719342
[TBL] [Abstract][Full Text] [Related]
6. Use of bioinformatic analyses in identifying characteristic genes and mechanisms active in the progression of idiopathic thrombocytopenic purpura in individuals with different phenotypes.
Zhang M; Guo B
J Int Med Res; 2020 Nov; 48(11):300060520971437. PubMed ID: 33222560
[TBL] [Abstract][Full Text] [Related]
7. Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.
Mathias SD; Gao SK; Miller KL; Cella D; Snyder C; Turner R; Wu A; Bussel JB; George JN; McMillan R; Wysocki DK; Nichol JL
Health Qual Life Outcomes; 2008 Feb; 6():13. PubMed ID: 18261217
[TBL] [Abstract][Full Text] [Related]
8. Management of immune thrombocytopenic purpura: an update.
Warrier R; Chauhan A
Ochsner J; 2012; 12(3):221-7. PubMed ID: 23049459
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune haematological disorders.
Provan D
Clin Med (Lond); 2001; 1(6):447-51. PubMed ID: 11792082
[No Abstract] [Full Text] [Related]
10. Immune Thrombocytopenia- Will it Stay or go Away?
Bafna V
Indian Pediatr; 2024 Jun; 61(6):519-520. PubMed ID: 38872289
[No Abstract] [Full Text] [Related]
11. Immune thrombocytopenia.
Kistangari G; McCrae KR
Hematol Oncol Clin North Am; 2013 Jun; 27(3):495-520. PubMed ID: 23714309
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based management of immune thrombocytopenia: ASH guideline update.
Neunert CE; Cooper N
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):568-575. PubMed ID: 30504359
[TBL] [Abstract][Full Text] [Related]
13. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
Rodeghiero F; Stasi R; Gernsheimer T; Michel M; Provan D; Arnold DM; Bussel JB; Cines DB; Chong BH; Cooper N; Godeau B; Lechner K; Mazzucconi MG; McMillan R; Sanz MA; Imbach P; Blanchette V; Kühne T; Ruggeri M; George JN
Blood; 2009 Mar; 113(11):2386-93. PubMed ID: 19005182
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of immune thrombocytopenic purpura.
Fogarty PF; Segal JB
Curr Opin Hematol; 2007 Sep; 14(5):515-9. PubMed ID: 17934361
[TBL] [Abstract][Full Text] [Related]
15. Pediatric ITP: is it different from adult ITP?
Despotovic JM; Grimes AB
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):405-411. PubMed ID: 30504339
[TBL] [Abstract][Full Text] [Related]
16. Cell Death Markers in Children with Immune Thrombocytopenic Purpura: A Preliminary Study.
Yahia S; Eldars W; Eldegla H; Mansour AK; Guaida M; Abdelkader MSA; Wahba Y
Indian J Hematol Blood Transfus; 2023 Oct; 39(4):635-641. PubMed ID: 37786823
[TBL] [Abstract][Full Text] [Related]
17. Predictor Factors for Chronicity in Immune Thrombocytopenic Purpura in Children.
Rosu VE; Roșu ST; Ivanov AV; Starcea IM; Streanga V; Miron IC; Mocanu A; Lupu A; Lupu VV; Gavrilovici C
Children (Basel); 2023 May; 10(6):. PubMed ID: 37371143
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist.
Xie C; Zhao H; Bao X; Fu H; Lou L
J Cell Mol Med; 2018 Nov; 22(11):5367-5377. PubMed ID: 30156363
[TBL] [Abstract][Full Text] [Related]
19. Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.
Osman ME
Sudan J Paediatr; 2012; 12(2):60-4. PubMed ID: 27493347
[TBL] [Abstract][Full Text] [Related]
20. Childhood immune thrombocytopenia: Clinical presentation and management.
Faki Osman ME
Sudan J Paediatr; 2012; 12(1):27-39. PubMed ID: 27493327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
